ImageKit , an AI-powered digital asset management and media delivery platform, today announced the launch of Creative Automation , a n ...

There is no sanctioning body or open source linter that can verify if a RESTful API conforms and complies with all applicable REST API naming conventions and best practices. However, REST API ...

You’ve probably scanned a QR code this week without thinking twice about it. It might’ve been on a menu, a package, or a flyer. What matters more is what happens after you scan it: you expect it to ...

Google’s John Mueller answered a question on Reddit about why Google picks one web page over another when multiple pages have duplicate content, also explaining why Google sometimes appears to pick ...

Content creation in 2026 follows a simple logic: the faster you can move from idea to execution, the more opportunities you capture. For marketers working across platforms, one of the most overlooked ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...